Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | GRM5 | P41594 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19620558 | 0.90 | KDM4E (0.34) | KDM4EPOLBMAPT | |
| SCHEMBL15627599 | 0.87 | KDM4E (0.41) | KDM4EPOLBMAPT | |
| SCHEMBL22902083 | 0.87 | KDM4E (0.39) | KDM4EPOLBMAPTGRM5 | |
| SCHEMBL19620541 | 0.86 | KDM4E (0.37) | KDM4EPOLBMAPTCYP1A2CYP3A4 | |
| SCHEMBL19620621 | 0.86 | MAPT (0.49) | KDM4EPOLBMAPTCYP1A2CYP3A4 | |
| SCHEMBL20367974 | 0.85 | MAPT (0.41) | KDM4EPOLBMAPT | |
| SCHEMBL20368252 | 0.84 | MAPT (0.39) | KDM4EPOLBMAPTGRM5 | |
| SCHEMBL19620595 | 0.84 | KCNA5 (0.36) | KDM4EPOLBMAPTCYP1A2CYP3A4 | |
| SCHEMBL19620538 | 0.84 | KDM4E (0.37) | KDM4EPOLBMAPTCYP1A2CYP3A4 | |
| SCHEMBL19620597 | 0.83 | DPP4 (0.38) | KDM4EPOLBMAPTGRM5CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2897607-B1 | INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER | RHODE ISLAND HOSPITAL (US) | 2017-11-22 | — | — | EP | disclosed |